Lōkahi Therapeutics, GlucoTrack unit, sets Oct. 14 launch for Qare GLP — 1 comparative health platform
Lōkahi Therapeutics, a GlucoTrack unit, introduced Qare, a real-time comparative health platform focused on GLP-1 medications. Public availability is scheduled to begin on Oct. 14, 2026, following an initial introduction timed to National GLP-1 Day. Platform targets cohort-based comparisons of patient-reported treatmen